Pages that link to "Q70030507"
Jump to navigation
Jump to search
The following pages link to Uremic cardiomyopathy: an inadequate left ventricular hypertrophy (Q70030507):
Displaying 50 items.
- Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy (Q30235107) (← links)
- Risk issues in renal transplantation: cardiac aspects (Q33542689) (← links)
- Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice. (Q33764626) (← links)
- Anesthesia for kidney transplant surgery (Q34091659) (← links)
- Central and peripheral adaptations to physical training in patients with end-stage renal disease (Q34338837) (← links)
- Cardiac Performance and Morphology in End-Stage Renal Disease (Q35107195) (← links)
- Echocardiography-based score to predict outcome after renal transplantation (Q35773354) (← links)
- Improvement of left ventricular function after renal transplantation in a patient with uremic cardiomyopathy: report of a case (Q36761076) (← links)
- The use of erythropoietin in renal failure (Q37767350) (← links)
- Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis (Q38756381) (← links)
- Recombinant human erythropoietin: implications for nephrology (Q39630695) (← links)
- Cardiac disease in patients with end-stage renal disease. (Q40447003) (← links)
- Cardiac and cerebrovascular disease in chronic uremia (Q40868227) (← links)
- The presence and impact of diastolic dysfunction on physical function and body composition in hemodialysis patients. (Q41263180) (← links)
- Cardiac Disease in Chronic Uremia: Pathogenesis (Q41547174) (← links)
- Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients (Q41925942) (← links)
- Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance (Q41979332) (← links)
- The effectiveness of renal transplantation as a treatment for recurrent uremic cardiomyopathy (Q43179426) (← links)
- Why is mortality higher on certain dialysis shifts? (Q44680113) (← links)
- Is parathormone a cardiac toxin in uremia? (Q46188041) (← links)
- Cardiac sympathetic dysautonomia in children with chronic kidney disease (Q46678557) (← links)
- Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy (Q46850755) (← links)
- Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries (Q46881103) (← links)
- Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy (Q50762519) (← links)
- Left Ventricular Morphology in Chronic Renal Failure by Echocardiography (Q50916200) (← links)
- Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. (Q52366312) (← links)
- Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism (Q57224037) (← links)
- Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern (Q64231913) (← links)
- Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis (Q68054624) (← links)
- Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients (Q69292721) (← links)
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietin (Q69430658) (← links)
- Myocardial calcification and cardiac dysfunction in chronic renal failure (Q70225312) (← links)
- Effects of acute and chronic uremia on active cation transport in rat myocardium (Q70239344) (← links)
- Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure (Q70616894) (← links)
- Characterization of myocardial tissue in patients undergoing maintenance hemodialysis by quantitative echocardiography (Q71581311) (← links)
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapy (Q72192935) (← links)
- Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy (Q72651976) (← links)
- Cardiac effects of exercise rehabilitation in hemodialysis patients (Q73029162) (← links)
- Determinants of left ventricular structure after kidney transplantation (Q73337997) (← links)
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 (Q73566942) (← links)
- Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study (Q73940092) (← links)
- Clinical Problem-Solving: High on the Differential (Q74305417) (← links)
- Echocardiographic changes in left ventricular morphology and function after successful renal transplantation (Q74339768) (← links)
- Left ventricular hypertrophy: a surrogate end point or correlate of cardiovascular events in kidney disease? (Q79267929) (← links)
- Left ventricular hypertrophy and risk factors for its development in uraemic patients (Q81222710) (← links)
- Cardiovascular effects of successful renal transplantation: a 30-month study on left ventricular morphology, systolic and diastolic functions (Q81680519) (← links)
- Impact of pre-existing left ventricular dysfunction on kidney transplantation outcomes: implications for patient selection (Q82978386) (← links)
- A Perfect Cardiomyopathic Storm (Q84081550) (← links)
- Characteristics of a Subset of Patients With Reversible Systolic Dysfunction in Chronic Kidney Disease (Q84187524) (← links)
- Should We Consider the Cardiovascular System While Evaluating CKD-MBD? (Q89920340) (← links)